Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Dopaminergic Modulation of Excitatory Transmission in the Anterior Cingulate Cortex of Adult Mice.

Darvish-Ghane S, Yamanaka M, Zhuo M.

Mol Pain. 2016 Jun 17;12. pii: 1744806916648153. doi: 10.1177/1744806916648153. Print 2016.

2.

Synaptic Plasticity, a Prominent Contributor to the Anxiety in Fragile X Syndrome.

Yang T, Zhao H, Lu C, Li X, Xie Y, Fu H, Xu H.

Neural Plast. 2016;2016:9353929. doi: 10.1155/2016/9353929. Epub 2016 Apr 28. Review.

3.

Functional magnetic resonance imaging in awake transgenic fragile X rats: evidence of dysregulation in reward processing in the mesolimbic/habenular neural circuit.

Kenkel WM, Yee JR, Moore K, Madularu D, Kulkarni P, Gamber K, Nedelman M, Ferris CF.

Transl Psychiatry. 2016 Mar 22;6:e763. doi: 10.1038/tp.2016.15.

4.

Autism Spectrum Disorders and Drug Addiction: Common Pathways, Common Molecules, Distinct Disorders?

Rothwell PE.

Front Neurosci. 2016 Feb 5;10:20. doi: 10.3389/fnins.2016.00020. eCollection 2016. Review.

5.

RNA-binding proteins, neural development and the addictions.

Bryant CD, Yazdani N.

Genes Brain Behav. 2016 Jan;15(1):169-86. doi: 10.1111/gbb.12273. Review.

6.

Fmr1 deficiency promotes age-dependent alterations in the cortical synaptic proteome.

Tang B, Wang T, Wan H, Han L, Qin X, Zhang Y, Wang J, Yu C, Berton F, Francesconi W, Yates JR 3rd, Vanderklish PW, Liao L.

Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):E4697-706. doi: 10.1073/pnas.1502258112. Epub 2015 Aug 11.

7.

Differential effects of dopamine-directed treatments on cognition.

Ashby FG, Valentin VV, von Meer SS.

Neuropsychiatr Dis Treat. 2015 Jul 29;11:1859-75. doi: 10.2147/NDT.S65875. eCollection 2015. Review.

8.

Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back.

Gross C, Hoffmann A, Bassell GJ, Berry-Kravis EM.

Neurotherapeutics. 2015 Jul;12(3):584-608. doi: 10.1007/s13311-015-0355-9. Review.

9.

Deficit in motor training-induced clustering, but not stabilization, of new dendritic spines in FMR1 knock-out mice.

Reiner BC, Dunaevsky A.

PLoS One. 2015 May 7;10(5):e0126572. doi: 10.1371/journal.pone.0126572. eCollection 2015.

10.

Quantitative profiling of brain lipid raft proteome in a mouse model of fragile X syndrome.

Kalinowska M, Castillo C, Francesconi A.

PLoS One. 2015 Apr 7;10(4):e0121464. doi: 10.1371/journal.pone.0121464. eCollection 2015.

11.

Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes.

Wang H, Pati S, Pozzo-Miller L, Doering LC.

Front Cell Neurosci. 2015 Feb 26;9:55. doi: 10.3389/fncel.2015.00055. eCollection 2015. Review.

12.

Fragile X mental retardation protein: from autism to neurodegenerative disease.

Wang H.

Front Cell Neurosci. 2015 Feb 12;9:43. doi: 10.3389/fncel.2015.00043. eCollection 2015. No abstract available.

13.

Serotonin dysregulation in Fragile X Syndrome: implications for treatment.

Hanson AC, Hagerman RJ.

Intractable Rare Dis Res. 2014 Nov;3(4):110-7. doi: 10.5582/irdr.2014.01027. Review.

14.

Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures.

Myrick LK, Deng PY, Hashimoto H, Oh YM, Cho Y, Poidevin MJ, Suhl JA, Visootsak J, Cavalli V, Jin P, Cheng X, Warren ST, Klyachko VA.

Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):949-56. doi: 10.1073/pnas.1423094112. Epub 2015 Jan 5.

15.

Human FMRP contains an integral tandem Agenet (Tudor) and KH motif in the amino terminal domain.

Myrick LK, Hashimoto H, Cheng X, Warren ST.

Hum Mol Genet. 2015 Mar 15;24(6):1733-40. doi: 10.1093/hmg/ddu586. Epub 2014 Nov 20.

16.

Prevalence of restless legs syndrome and sleep quality in carriers of the fragile X premutation.

Summers SM, Cogswell J, Goodrich JE, Mu Y, Nguyen DV, Brass SD, Hagerman RJ.

Clin Genet. 2014 Aug;86(2):181-4.

17.

Fragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administration.

Smith LN, Jedynak JP, Fontenot MR, Hale CF, Dietz KC, Taniguchi M, Thomas FS, Zirlin BC, Birnbaum SG, Huber KM, Thomas MJ, Cowan CW.

Neuron. 2014 May 7;82(3):645-58. doi: 10.1016/j.neuron.2014.03.028.

18.

Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission.

Daigle TL, Ferris MJ, Gainetdinov RR, Sotnikova TD, Urs NM, Jones SR, Caron MG.

Neuropsychopharmacology. 2014 Sep;39(10):2450-62. doi: 10.1038/npp.2014.97. Epub 2014 Apr 29.

19.

Lipid rafts: a signaling platform linking cholesterol metabolism to synaptic deficits in autism spectrum disorders.

Wang H.

Front Behav Neurosci. 2014 Mar 27;8:104. doi: 10.3389/fnbeh.2014.00104. eCollection 2014. No abstract available.

20.

Degraded speech sound processing in a rat model of fragile X syndrome.

Engineer CT, Centanni TM, Im KW, Rahebi KC, Buell EP, Kilgard MP.

Brain Res. 2014 May 20;1564:72-84. doi: 10.1016/j.brainres.2014.03.049. Epub 2014 Apr 5.

Items per page

Supplemental Content

Write to the Help Desk